Related Experiment Videos
Management of infantile polyposis syndrome
G J Stiff1, A Alwafi, H Jenkins
1Department of Paediatric Surgery, University Hospital of Wales, Cardiff.
Insights
Management of generalised infantile polyposis syndrome is challenging. This case report details a patient whose condition worsened despite polypectomy, blood transfusions, and sulindac, ultimately leading to death from septicaemia.
Area of Science:
- Gastroenterology
- Pediatric Surgery
- Clinical Genetics
Background:
- Generalised infantile polyposis syndrome (GIPS) is a rare, severe gastrointestinal disorder.
- Characterized by diffuse polyps throughout the colon and rectum, leading to significant morbidity.
Observation:
- A pediatric case of GIPS is presented to illustrate complex management challenges.
- The patient underwent repeated endoscopic polypectomies to reduce polyp burden.
- Daily blood product transfusions were administered to manage associated anemia.
Findings:
- Despite aggressive interventions including sulindac (a non-steroidal anti-inflammatory drug), the patient's condition progressively deteriorated.
- The syndrome proved refractory to standard and experimental therapeutic approaches.
- The case culminated in fatal septicaemia, underscoring the syndrome's severity.
Implications:
- This case highlights the critical need for novel therapeutic strategies for GIPS.
- Effective management protocols for GIPS remain elusive, necessitating further research.
- Early diagnosis and multidisciplinary care are crucial for potentially improving outcomes in pediatric polyposis syndromes.
Abstract:
A boy with generalised infantile polyposis syndrome is reported to highlight the difficulties in management. Despite attempts to reduce polyp mass by regular endoscopic polypectomy, daily transfusions of blood products, and a trial of the non-steroidal anti-inflammatory agent sulindac, his condition gradually deteriorated and he died of septicaemia.